Stella Plevan, PhD
- PROFESSOR | Psychiatry
Research Topics:
Amyotrophic Lateral Sclerosis, Brain, Cerebral Cortex, Chromatin, Depression, Epigenetics, Epigenomics, Evolution, Gene Expressions, Gene Regulation, Genomics, Molecular Biology, Neurobiology, Neuroscience, RNA, SchizophreniaStella Dracheva (Plevan) is a Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. She is a member of the Friedman Brain Institute. She is also a VA/MIRECC Research Scientist at the James J. Peters VA Medical Center.
Stella Dracheva received her bachelor and doctorate degrees in Biochemistry from the Moscow State University in Russia.
Dr. Dracheva's laboratory studies the neurobiology of neuropsychiatric and neurodegenerative disorders through understanding the cell-type-specific epigenetic regulation of gene expression. Her team applie a combination of molecular biology, biochemistry, and bioinformatics approaches to address these complex questions.
Visit our website for more information on our research: https://labs.icahn.mssm.edu/dracheva/
Multi-Disciplinary Training Area
Neuroscience [NEU]Education
PhD, Moscow State University
Research
Stella Dracheva’s laboratory studies the neurobiology of neuropsychiatric and neurodegenerative disorders through understanding the cell-type-specific epigenetic regulation of gene expression. Her team applies a combination of Molecular Biology, Biochemistry, and Bioinformatics approaches to address these complex questions. Visit our website: https://labs.icahn.mssm.edu/dracheva/
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Plevan did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.